Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,288.05
      (
      -0.27%
      )
      US Tech 100
      14,344.00
      (
      0.16%
      )
      Dow Jones
      33,507.50
      (
      -0.47%
      )
      Brent Oil
      92.015
      (
      0.0%
      )
      Bitcoin
      27,132.81
      (
      0.63%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Invitae Corporation (NVTA)

      7. Invitae Corporation (NVTA) News

      NVTA

      Invitae (NVTA)

      Invitae Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVTA
      DateTimeSourceHeadlineSymbolCompany
      09/29/20238:00PMDow Jones NewsFDA Gives Marketing Authorization to Invitae Test for Cancer Genes NYSE:NVTAInvitae Corporation
      09/27/20234:29PMEdgar (US Regulatory)Form 8-K - Current report NYSE:NVTAInvitae Corporation
      09/25/20236:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NYSE:NVTAInvitae Corporation
      09/25/20234:30PMPR Newswire (US)Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO NYSE:NVTAInvitae Corporation
      09/22/20235:02PMEdgar (US Regulatory)Form 8-K - Current report NYSE:NVTAInvitae Corporation
      09/22/20234:30PMPR Newswire (US)Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard NYSE:NVTAInvitae Corporation
      09/14/20235:21PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securities NYSE:NVTAInvitae Corporation
      08/28/20234:02PMPR Newswire (US)Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer NYSE:NVTAInvitae Corporation
      08/23/20238:12AMEdgar (US Regulatory)Form 8-K - Current report NYSE:NVTAInvitae Corporation
      08/15/20237:30AMPR Newswire (US)Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer NYSE:NVTAInvitae Corporation
      08/14/20234:02PMPR Newswire (US)Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO NYSE:NVTAInvitae Corporation
      08/10/20234:03PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)] NYSE:NVTAInvitae Corporation
      08/10/20234:01PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)] NYSE:NVTAInvitae Corporation
      08/10/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of Effectiveness NYSE:NVTAInvitae Corporation
      08/10/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of Effectiveness NYSE:NVTAInvitae Corporation
      08/09/20239:22AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statement NYSE:NVTAInvitae Corporation
      08/09/20239:20AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statement NYSE:NVTAInvitae Corporation
      08/08/20234:40PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)] NYSE:NVTAInvitae Corporation
      08/08/20234:09PMEdgar (US Regulatory)Form 8-K - Current report NYSE:NVTAInvitae Corporation
      08/08/20234:01PMPR Newswire (US)Invitae Reports Second Quarter 2023 Financial Results NYSE:NVTAInvitae Corporation
      07/26/20234:01PMPR Newswire (US)Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 NYSE:NVTAInvitae Corporation
      07/05/20234:53PMEdgar (US Regulatory)Form 8-K - Current report NYSE:NVTAInvitae Corporation
      07/03/20232:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securities NYSE:NVTAInvitae Corporation
      06/15/20234:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NYSE:NVTAInvitae Corporation
      06/15/20234:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NYSE:NVTAInvitae Corporation
      05/31/20236:59AMPR Newswire (US)Invitae to Present at the William Blair 43rd Annual Growth Stock Conference NYSE:NVTAInvitae Corporation
      05/26/20238:01AMPR Newswire (US)New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology NYSE:NVTAInvitae Corporation
      05/25/20237:00PMPR Newswire (US)Invitae Announces CFO Transition and Selection of Veteran Finance Executive Christine Gorjanc as Interim CFO NYSE:NVTAInvitae Corporation
      05/24/20235:08PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a) NYSE:NVTAInvitae Corporation
      05/18/20234:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NYSE:NVTAInvitae Corporation
       Showing the most relevant articles for your search:NYSE:NVTA
      Your Recent History
      LSE
      GKP
      Gulf Keyst..
      LSE
      QPP
      Quindell
      FTSE
      UKX
      FTSE 100
      LSE
      IOF
      Iofina
      FX
      GBPUSD
      UK Sterlin..
      Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

      Register now to create your own custom streaming stock watchlist.

      Log in to InvestorsHub
      Register Now